Walleye Capital’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.53M Sell
2024
Q4
$3.13M Buy
2023
Q2
Sell
2023
Q1
$2.89M Buy
2022
Q4
$423K Sell
2022
Q3
$657K Sell
2022
Q2
$1.11M Buy
2022
Q1
$1.58M Buy